Muutke küpsiste eelistusi

E-raamat: Medical Management of Cancer-treatment Induced Emesis

Edited by
  • Formaat: 248 pages
  • Ilmumisaeg: 01-Nov-2024
  • Kirjastus: Taylor & Francis Ltd
  • Keel: eng
  • ISBN-13: 9781040290484
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 143,00 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Raamatukogudele
Medical Management of Cancer-treatment Induced EmesisSuurem pilt
  • Formaat: 248 pages
  • Ilmumisaeg: 01-Nov-2024
  • Kirjastus: Taylor & Francis Ltd
  • Keel: eng
  • ISBN-13: 9781040290484
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Now there's an in-depth and up-to-date reference you can turn to for help in managing two of the most common side effects of anti-cancer treatments: nausea and vomiting. Get the details on how the clinical application of 5-hydroxytryptamine receptor antagonists has transformed the management of these side effects -- and how it can dramatically improve the quality of life for your patients.

* Presents a detailed overview of the management of cancer treatment-induced emesis in various treatment settings * Focuses on the mechanisms and use of 5-HT3 receptor antagonists * Includes up-to-date results from major international trials * Keeps you completely informed with contributions from the points of view of the nurse and the patient

First published in 1997. Routledge is an imprint of Taylor & Francis, an informa company.

1. The evolution of antiemetic treatment
2. Methodology of trials for treating nausea and vomiting
3. Pharmacology of serotonin and its receptors
4. Clinical aspects and prognostic factors of nausea and vomiting after chemotherapy
5. Platinum-induced acute nausea and vomiting
6. Platinum-induced delayed emesis
7. Treatment of moderately emetogenic chemotherapy-induced nausea and vomiting
8. Treatment of radiotherapy-induced nausea and vomiting
9. Prevention of nausea and vomiting in repeat courses
10. Anticipatory nausea and vomiting: models, mechanisms and management
11. Are there differences between 5-HT3 receptor antagonists?
12. Quality of life
13. Patients' point of view
14. Emesis: A challenge for nurses
15. Nausea and vomiting in children
16. Side-effects of antiemetics

Mario A. Dicato M.D. Department of Haematology-Oncology, Centre Hospitalier de Luxembourg.
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97810402904842e.html
Märksõnad: